[Identification of myeloid dendritic cells in peritoneal fluid by flow cytometry]

Area of Science:

• Immunology
• Gynecologic Oncology

Background:

• Dendritic cells (DCs) are crucial antigen-presenting cells (APCs) that initiate adaptive immune responses.
• Myeloid DCs are a key subset of APCs involved in immune surveillance and response.
• Understanding DC populations in the peritoneal fluid is important for gynecologic conditions.

Purpose of the Study:

• To identify and quantify myeloid dendritic cells (DCs) in the peritoneal fluid of women diagnosed with nonmalignant ovarian tumors.
• To compare the prevalence of myeloid DCs in the peritoneal fluid of women with ovarian tumors versus those with unexplained infertility.

Main Methods:

• Flow cytometry was employed to detect and characterize myeloid DCs within peritoneal fluid samples.
• Myeloid DCs were identified as mononuclear cells expressing high levels of HLA-DR and CD33, with negative expression of CD14 and CD16.
• DC counts were quantified as a percentage of total mononuclear cells in the peritoneal fluid.

Main Results:

• Myeloid dendritic cells (DCs) were successfully detected in the peritoneal fluid of women with ovarian tumors.
• The percentage of DCs in peritoneal fluid was significantly higher in patients with ovarian tumors (3.02%) compared to women with unexplained infertility (1.72%).
• The proportion of DCs in peritoneal fluid was notably higher than observed in peripheral blood samples.

Conclusions:

• Myeloid DCs are present in the peritoneal fluid of women with nonmalignant ovarian tumors.
• An increased presence of myeloid DCs in peritoneal fluid may be associated with ovarian tumors.
• Further research is warranted to explore the role of these DCs in the context of ovarian pathology.